Sphinx’s Pharmaceutical Outsourcing Service Base Breaks Ground in TEDA

On June 8th, Sphinx Scientific Laboratory (Tianjin) Co., Ltd. broke ground on its pharmaceutical outsourcing service base project in TEDA. The base covers about 12,000 square meters of land. With a construction area of more than 20,000 square meters, a corporate headquarters building integrating R&D and production functions will be built. It is scheduled to be completed and put into operation in May 2023. Once completed, the CDMO’s need for domestic innovative drugs and high value-added intermediates will be greatly met.

Sphinx is a CDMO company dedicated to serving domestic innovative drugs. Since 2012, it has been rated as a national high-tech enterprise. The company has created a number of unique technologies, obtained 27 invention patents, and completed nearly 3,000 R&D projects excellently for over a decade. Among them, more than 30 projects have entered the late clinical phase, and some have achieved commercial production.